GlobalData Conferences Presents: Digital Transformation in the Healthcare Sector: How and Why Has Digital Transformation Become a Necessity?

Wednesday, 2nd Mar 2022 at 15:00 GMT / 10:00 EST


The Pharmaceutical industry is undergoing constant change due to declining profit margins, cost pressure, and necessity to replenish pipelines and maximize peak sales, while adhering to stringent regulatory and legislative requirements. Although innovative technologies have been adopted to ease these pressures, the pandemic increased pressure on the digitalization of the sector. The acceleration of this digital transformation will undoubtedly have a lasting impact on the resilience, competitiveness, and growth of many businesses.

This two-hour forty-five-minute virtual conference brings together the trusted insight and intelligence from GlobalData’s Pharma practice to explore the industry’s preparation for digital transformation. With a comprehensive agenda covering the barriers and necessities required to successfully innovate, levels of investment, and the importance of emerging technologies, this conference will enable you to see how your business fits into the bigger picture.

Aimed at those keen to understand global trends and industry themes, our virtual conference will help you to:

  • Explore how innovations are transforming the healthcare industry and what business functions and processes are impacted the most
  • Uncover current and future technology-related investment trends and how these investment priorities have changed in the light of COVID-19
  • Gain insight from ‘alternative’ data sets, including company hiring trends, to understand how industry players are embracing digital transformation


Intended Audience:

  • Brand & Product Managers
  • Strategy Planners and Directors
  • Global & Regional Marketing Directors
  • Insight Managers and Directors


Areas Covered:

  • Digital transformation enablers and barriers
  • Technological investment
  • COVID-19 impact on digitalization efforts
  • Decentralized clinical trials
  • Data-generating areas of healthcare, including remote patient monitoring and mobile apps
  • Alternative datasets, from company filings and deals, to job analytics



Welcome & Introduction – 15 mins

Dr Bonnie Bain, Global Head and EVP of Healthcare Operations and Strategy, will give a brief introduction to the digital transformation of the Pharmaceutical industry, and how the pandemic has affected this.

Forecasts & Prospects – Technology Investment Trends – 30 mins

Urte Jakimaviciute MSc, Senior Director of Market Research, will then provide an overview of the technological investment trends dominating the healthcare sector, and the impact COVID-19 has had on these. What technologies are businesses in the healthcare sector prioritizing for current and future investments? Which emerging technologies will have the most disruptive power in your sector in the next two years?

Industry Insights – 60 mins

Priya Nair, Analyst for GlobalData’s Clinical Trials Intelligence, will highlight how the incorporation of innovative technologies is helping to address clinical trials disruptions and accelerate the move towards decentralized/virtual trials.

Kitty Whitney MSc, Director of Pharma Thematic Analysis, and Wafaa Hassan, Digital Healthcare Analyst, will discuss how the pandemic led to a significant boost to data-generating areas of healthcare such as wearables, remote patient monitoring, and mobile apps, leading to increased volumes and variety of information that companies can access, collect, and analyze.

Thematic Analysis – 30 mins

Sarah Coop, from GlobalData’s Thematic Analysis team, will then take you through the alternative datasets. From company filings and deals to job analytics, see how the Healthcare industry is responding to the need to digitalize. Sarah will then list the winners and losers in this exciting space.

Future Prospects – 10 mins

In this section, Dr Bonnie Bain will examine the key barriers and obstacles that the Pharmaceutical industry needs to overcome to succeed at embracing digital transformation.

Conclusions & Outlook – 10 mins

In this penultimate segment, our panel will be drawing together their research to provide insights on the future of the Biopharmaceutical industry.

What is the market outlook now? What technologies are poised to have the most impact? Who are the players keying into the technologies that will shape the market in the future? Acquire all the information you’ll need to go to market.

Q&A – 10 mins

This is your exclusive chance to field questions to our market-leading experts, as they apply to the topic at hand.


Kitty Whitney, Director of Pharma Thematic Analysis

Kitty Whitney, MSc, is the Director of Thematic Analysis in the pharma division of GlobalData, London, where she is responsible for delivering all research projects within the space. Her pharmaceutical industry knowledge is comprehensive, gained from her time working within Healthcare at Home’s business strategic group, and during her time in analysis positions at Intelligentsia Worldwide and IMS Health.

Bonnie Bain, Global Head and Executive Vice President of Healthcare Operations and Strategy

Dr Bonnie Bain has over 20 years’ experience in the healthcare sector and a proven track record of developing innovative solutions on both the client and agency sides of the business. Under her leadership, GlobalData have launched several premium syndicated reports, analytical tools and databases in the pharmaceuticals and medical devices space.

Prior to joining GlobalData, Bonnie was Vice President and Global Research & Analysis Director for Informa’s Pharma Division, which includes Datamonitor Healthcare, Scrip Group, and Business Insight.

Urte Jakimaviciute, Senior Director of Market Research

Urte Jakimaviciute, MSc, is Senior Director of Market Research in the healthcare division of GlobalData, London, with more than 10 years of experience in the market research industry. Her primary responsibility includes managing the market research process for the syndicated portfolio, thematic reports, and custom consulting projects.

Sarah Coop, Associate Analyst

Sarah Coop is an Associate Analyst in GlobalData’s Thematic Research team. Sarah has covered the themes making the largest impact across the world of FMCG, assisting in the syndicated research process on topics such as AI, ESG, and IoT

Priya Nair, Analyst

Priya Nair, MsC is an Analyst at GlobalData in London, UK, where her primary responsibilities include producing analytical reports, analyzing and determining clinical trial trends, improving and maintaining database functionality through quality assurance testing, and updating and monitoring GlobalData’s Clinical Trials Intelligence Database.

Wafaa Hassan, Digital Healthcare Analyst

Wafaa Hassan is a Digital Healthcare Analyst for GlobalData’s Pharma digital team. In her role, she contributes to analysis reports on disruptive themes and technologies.

Prior to joining GlobalData, Wafaa studied Biomedical Engineering (BEng) and an MSc in Healthcare Management at City, University of London.